Rennova Health Inc (RNVA)

[nfrequent]

Undervalued no doubt. Huge revenue growth. P/L in the black Q1. All current and SEC compliant. All indications point to continued improvement in revenue and earnings. $20 million in hard assets plus the federal CAH designation which is proving to be quite valuable though not listed as an asset. The stock price has to catch up sooner or later.